Related Experiment Video
Updated: May 1, 2026
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
The challenges and innovations for therapy in children with epilepsy
Jo M Wilmshurst1, Anne T Berg2, Lieven Lagae3
1Red Cross War Memorial Children's Hospital, University of Cape Town, Rondebosch 7700, South Africa.
Insights
Recent advances in childhood epilepsy include increased genetic diagnoses like Dravet syndrome. However, global treatment guidelines are lacking, highlighting a need for evidence-based practices in pediatric epilepsy management.
Area of Science:
- Pediatric Neurology
- Clinical Genetics
- Epileptology
Background:
- Significant progress in diagnosing and managing childhood epilepsy over 15 years.
- Increased identification of genetic causes for epilepsy syndromes, e.g., Dravet syndrome (SCN1A gene mutations).
- International League Against Epilepsy reclassification prompts reassessment of diagnostic methods.
Purpose of the Study:
- To review current data and novel therapeutic strategies for pediatric epilepsy.
- To identify gaps in evidence-based practices for global treatment guidelines.
- To highlight standard practices in pediatric epilepsy management that may lack clinical evidence.
Main Methods:
- Comprehensive review of existing literature on pediatric epilepsy diagnosis and management.
- Analysis of recent advances in genetic testing and classification systems.
- Discussion of therapeutic approaches and their evidence base.
Main Results:
- Marked increase in genetic diagnoses for childhood epilepsy syndromes.
- Shortage of Class I evidence-based data for worldwide treatment guideline development.
- Need for comprehensive management strategies across all care levels for pediatric epilepsy.
Conclusions:
- Despite advances, global challenges remain in the diagnosis and optimal management of childhood epilepsy.
- Current practices may not always be evidence-based, necessitating a critical evaluation.
- Development of robust, evidence-based guidelines is crucial for improving pediatric epilepsy care worldwide.
Abstract:
Major advances have been made in the diagnosis, evaluation and management of children with epilepsy over the past 15 years. There has been a marked increase in genetic diagnoses of a number of key childhood-onset epilepsy syndromes, such as Dravet syndrome, which has been linked to mutations in the SCN1A gene. The reorganization and reclassification of epilepsies, devised by the International League Against Epilepsy, has stimulated specialists to reassess their diagnostic practices; however, many studies have not addressed the global issues in treating children with epilepsy-specifically, the challenges of diagnosis through to optimal, and appropriate, therapeutic management. Also, Class I evidence-based data that are needed as a foundation for the development of treatment guidelines worldwide are lacking. Epilepsy is common, and the impact of this disease crosses age ranges and should be managed at all levels of care from community to quaternary care. In this Review, existing data and new therapeutic management approaches are discussed with the aim of highlighting the incidence of standard practices that may not be based on clinical evidence.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:30Electroconvulsive Therapy
01:22Epilepsy ll: Types
01:20Seizures l: Introduction
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:14Antiepileptic Drugs: Glutamate Antagonists